BlackRock, Inc. 13D and 13G filings for Standard BioTools Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-30 11:18 am Sale | 2026-06-30 | 13G | STANDARD BIOTOOLS INC. LAB | BlackRock, Inc. BLK | 7,911,347 2.000% | -14,540,768 (-64.76%) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | STANDARD BIOTOOLS INC. LAB | BlackRock, Inc. BLK | 22,452,115 6.000% | 0 (Unchanged) | Filing |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | STANDARD BIOTOOLS INC. LAB | BlackRock, Inc. BLK | 22,452,115 6.000% | 20,434,905 (+1013.03%) | Filing |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | STANDARD BIOTOOLS INC. LAB | BlackRock, Inc. BLK | 2,017,210 2.600% | -4,234,020 (-67.73%) | Filing |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | STANDARD BIOTOOLS INC. LAB | BlackRock, Inc. BLK | 6,251,230 8.200% | 673,271 (+12.07%) | Filing |